Santa Cruz Biotechnology offers a broad range of HSV-2 Antibodies for the detection and analysis of the herpes simplex virus type 2. Monoclonal HSV-2 Antibodies support various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Herpes simplex virus type 2 is primarily associated with genital herpes, a common sexually transmitted infection that can lead to significant morbidity. Understanding the biology of HSV-2 is crucial for developing effective treatments and vaccines, as well as for studying its role in viral pathogenesis and immune response. HSV-2 monoclonal antibodies enable detailed investigation of viral protein expression, localization, and interactions within host cells. Researchers can utilize HSV-2 monoclonal antibodies to track viral entry, replication, and spread throughout infected tissues. Advanced research techniques incorporating HSV-2 monoclonal antibodies help identify potential therapeutic targets and evaluate treatment efficacy. Santa Cruz Biotechnology monoclonal HSV-2 Antibodies support the scientific community in advancing our understanding of herpes simplex virus infections and developing improved therapeutic strategies.